Xu David, Garg Elisha, Lee Kook, Sakurada Yoichi, Amphornphruet Atchara, Phasukkijwatana Nopasak, Liakopoulos Sandra, Pautler Scott Eugene, Kreiger Allan E, Yzer Suzanne, Lee Won Ki, Sadda SriniVas, Freund K Bailey, Sarraf David
Stein Eye Institute, University of California Los Angeles, Los Angeles, California, USA
Stein Eye Institute, University of California Los Angeles, Los Angeles, California, USA.
Br J Ophthalmol. 2022 Apr;106(4):576-581. doi: 10.1136/bjophthalmol-2019-315550. Epub 2020 Dec 21.
BACKGROUND/AIMS: To analyse the long-term anatomic and visual outcomes of patients with peripapillary pachychoroid syndrome (PPS), a recently described entity in the pachychoroid disease spectrum.
This study retrospectively included patients from several retina centres worldwide. Visual acuity (VA), retinal thickness and choroidal thickness at baseline, 6 months and final follow-up were assessed. Temporal trends in VA and anatomic characteristics were evaluated. Visual and anatomic outcomes in eyes that were observed versus those that were treated were analysed.
Fifty-six eyes of 35 patients were included with mean follow-up of 27±17 months. Median VA was 20/36 at baseline and remained stable through follow-up (p=0.77). Retinal thickness significantly decreased subfoveally (p=0.012), 1.5 mm nasal to the fovea (p=0.002) and 3.0 mm nasal to the fovea (p=0.0035) corresponding to areas of increased thickening at baseline. Choroidal thickness significantly decreased subfoveally (p=0.0030) and 1.5 mm nasal to the fovea (p=0.0030). Forty-three eyes were treated with modalities including antivascular endothelial growth factor injection, photodynamic therapy, and others. VA remained stable in treated eyes over follow-up (p=0.67). An isolated peripapillary fluid pocket in the outer nuclear layer was characteristic of PPS.
Patients with PPS experienced decreased retinal oedema and decreased choroidal thickening throughout the course of disease. While some patients experienced visual decline, the overall visual outcome was relatively favourable and independent of trends in retinal or choroidal thickening.
背景/目的:分析视乳头周围厚脉络膜综合征(PPS)患者的长期解剖学和视觉预后,PPS是厚脉络膜疾病谱中最近描述的一种疾病。
本研究回顾性纳入了来自全球多个视网膜中心的患者。评估了基线、6个月和最终随访时的视力(VA)、视网膜厚度和脉络膜厚度。评估了VA和解剖学特征的时间趋势。分析了观察眼与治疗眼的视觉和解剖学预后。
纳入了35例患者的56只眼,平均随访27±17个月。基线时的中位VA为20/36,随访期间保持稳定(p=0.77)。视网膜厚度在黄斑中心凹下(p=0.012)、黄斑中心凹鼻侧1.5mm处(p=0.002)和黄斑中心凹鼻侧3.0mm处(p=0.0035)显著降低,对应于基线时增厚增加的区域。脉络膜厚度在黄斑中心凹下(p=0.0030)和黄斑中心凹鼻侧1.5mm处(p=0.0030)显著降低。43只眼接受了包括抗血管内皮生长因子注射、光动力疗法等在内的治疗。治疗眼的VA在随访期间保持稳定(p=0.67)。外层核层孤立的视乳头周围液腔是PPS的特征。
PPS患者在疾病过程中视网膜水肿减轻,脉络膜增厚减轻。虽然一些患者出现视力下降,但总体视觉预后相对良好,且与视网膜或脉络膜增厚趋势无关。